FDG-PET in Lymphoma: Nuclear Medicine Perspective

被引：0
作者：
Cerci, Juliano Julio [1 ,2 ]
Zanoni, Lucia [3 ]
Meneghetti, Jose C. [2 ]
Fanti, Stefano [3 ]
机构：
[1] Quanta Diagnost Nucl, BR-80045170 Curitiba, Parana, Brazil
[2] Univ Sao Paulo, Sch Med, Heart Inst InCor, BR-05403900 Sao Paulo, Brazil
[3] Univ Bologna, Azienda Osped Univ Bologna Policlin S Orsola Malp, Policlin S Orsola, I-40138 Bologna, Italy
来源：
PET CLINICS | 2012年 / 7卷 / 01期
关键词：
Positron emission tomography; F-18-Fluorodeoxyglucose; Lymphoma; Staging;
D O I：
10.1016/j.cpet.2011.12.001
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Positron emission tomography (PET) is a sectional molecular imaging procedure that allows evaluation of the metabolism at a molecular and cellular level. For a PET scan, the patient is injected with a radiotracer, such as F-18-fluorodeoxyglucose (FDG). FDG PET-computed tomography has become an established modality for metabolic staging and plays an important role in the major steps of evaluation and treatment of most lymphoma subtypes, with significant impact in the initial staging, posttherapy evaluation, and suspect of relapse of disease. However, whenever the information of PET results is translated to changing treatment, especially in cases of further treatment, biopsy confirmation should always be made when possible.
引用
收藏
页码：21 / +
页数：14
相关论文
共 92 条
  • [1] Bangerter M, 1999, ACTA ONCOL, V38, P799
  • [2] Becherer A, 2003, Q J NUCL MED, V47, P14
  • [3] Predictive value and diagnostic accuracy of F-18-fluoro-deoxy-glucose positron emission tomography treated grade 1 and 2 follicular lymphoma
    Bishu, Shrinivas
    Quigley, Joanna M.
    Bishu, Shreenath R.
    Olsasky, Sarah M.
    Stem, Richard A.
    Shostrom, Valerie K.
    Holdeman, Karen P.
    Paknikar, Subash
    Armitage, James O.
    Hankins, Jordan H.
    [J]. LEUKEMIA & LYMPHOMA, 2007, 48 (08) : 1548 - 1555
  • [4] PET and PET/CT for response evaluation in lymphoma: Current practice and developments
    Brepoels, Lieselot
    Stroobants, Sigrid
    Verhoef, Gregor
    [J]. LEUKEMIA & LYMPHOMA, 2007, 48 (02) : 270 - 282
  • [5] Classical Hodgkin's lymphoma in adults: guidelines of the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation on initial work-up, management, and follow-up
    Brusamolino, Ercole
    Bacigalupo, Andrea
    Barosi, Giovanni
    Biti, Giampaolo
    Gobbi, Paolo G.
    Levis, Alessandro
    Marchetti, Monia
    Santoro, Armando
    Zinzani, Pier Luigi
    Tura, Sante
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (04): : 550 - 565
  • [6] Buchmann I, 2001, CANCER, V91, P889
  • [7] RESIDUAL MASS IN LYMPHOMA MAY NOT BE RESIDUAL DISEASE
    CANELLOS, GP
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (06) : 931 - 933
  • [8] CARBONE PP, 1971, CANCER RES, V31, P1860
  • [9] Detection of lymphoma in bone marrow by whole-body positron emission tomography
    Carr, R
    Barrington, SF
    Madan, B
    O'Doherty, MJ
    Saunders, CAB
    van der Walt, J
    Timothy, AR
    [J]. BLOOD, 1998, 91 (09) : 3340 - 3346
  • [10] Predictive value of early 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) during salvage chemotherapy in relapsing/refractory Hodgkin lymphoma (HL) treated with high-dose chemotherapy
    Castagna, Luca
    Bramanti, Stefania
    Balzarotti, Monica
    Sarina, Barbara
    Todisco, Elisabetta
    Anastasia, Antonella
    Magagnoli, Massimo
    Mazza, Rita
    Nozza, Andrea
    Giordano, Laura
    Rodari, Marcello
    Rinifilo, Eva
    Chiti, Arturo
    Santoro, Armando
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2009, 145 (03) : 369 - 372
12345678910